US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

Scientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any genetic material. This removes the risk of infection while still triggering an ...

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

POLIO has emerged as a major challenge in Pakistan. It is not simply a challenge in the health sector, but has also become ...

Five countries reported polio cases this week, including Pakistan, which reported three cases of wild poliovirus type (WPV1), ...

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

Funding cuts, including the U.S. withdrawal from WHO, threaten the global fight against polio. Over $133 million expected ...

Coverage with measles-mumps-rubella (MMR), diphtheria-tetanus-acellular pertussis (DTaP), polio, and varicella, or chickenpox vaccines, all declined in more than 30 states last year compared with ...

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

The United States Agency for International Development (USAID) primarily funds humanitarian initiatives worldwide, supporting ...

The Regional Reference Laboratory for Polio Eradication at the National Institute of Health has confirmed a polio case from ...